Skip to main content
Log in

Treatment of pigmented villonodular synovitis with yttrium-90: Changes in immunologic features, Tc-99m uptake measurements, and MR imaging of one case

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Pigmented villonodular synovitis (PVNS) is an uncommon proliferative disease of synovium. We report a 35-year-old male with diffuse form of PVNS of left knee, treated with intraarticular injection of 5 mCi of yttrium-90 (Y-90) silicate colloid consisting of two doses with a 3-month interval between them. During follow-up, the affected knee showed clinical improvement and was accompanied by a decrease of the levels of soluble interleukin-2 receptor in sera and synovial fluids (SF). When compared to osteoarthritis subjects, SF lymphocyte subsets of this case before Y-90 therapy showed a lower CD4: CD8 cell ratio and absence of suppressor inducer cells (CD4+2H4+). The Tc-99m pertechnetate knee uptake indexes correlated well with clinical improvement. Serial magnetic resonance imaging revealed significant change one year after Y-90 therapy. The findings of immunological assessment suggested that immunoregulatory dysfunction may be related to the pathogenesis of PVNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Docken, W.P. Pigmented villonodullar synovitis: review with illustrative case reports. Semin Arthritis Rheum 1979, 9, 1–22.

    Article  CAS  PubMed  Google Scholar 

  2. Myers, B.W., Masi, A.T., Feigenbaum, S.L. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore) 1980, 59, 223–238.

    Article  CAS  Google Scholar 

  3. Granowitz, S.P., D'Antonio, J., Mankin, H.L. The pathogenesis and long-term end results of pigmented villonodular synovitis. Clin Orthop 1976, 114, 335–351.

    PubMed  Google Scholar 

  4. Hirohata, Kazushi. Light microscopic and electron microscopic studies of individual cells in pigmented villonodular synovitis and bursitis. Kobe J Med Sci 1968, 14, 251–279.

    CAS  PubMed  Google Scholar 

  5. Jaffe, H.L., Lichtenstein, Louis, Sutro, C.J. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol 1941, 31, 731–765.

    Google Scholar 

  6. Byers, P.D., Cotton, R.E., Deacon, O.W., et al. The diagnosis and treatment of pigmented villonodular synovitis. J Bone Joint Surg 1968, 50, 290–305.

    CAS  Google Scholar 

  7. Johansson, J.E., Ajjoub, S., Coughlin, L.P., Wener, J.A., Cruess, R.L. Pigmented villonodular synovitis of joints. Clin Orthop 1982, 163, 159–166.

    PubMed  Google Scholar 

  8. Rao, A.S., Vigorita, M.J. Pigmented villonodular synovitis (Giant-cell tumor of tendon sheath and synovial membrane): a review of eighty one cases. J Bone Joint Surg 1984, 66-A, 76–94.

    Google Scholar 

  9. Wiss, D.A. Recurrent villonodular synovitis of the knee: successful treatment with yttrium-90. Clin Orthop 1982, 169, 139–144.

    PubMed  Google Scholar 

  10. O'Sullivan, M.M.O., Yates, D.B., Pritchard, M.H. Yttrium 90 synovectomy: a new treatment for pigmented villonodular synovitis. Br J Rheumatol. 1987, 26, 71–72.

    Article  PubMed  Google Scholar 

  11. Franssen, M.J.A.M., Boerbooms, A.M.T., Karthaus, R.P., Buijs, W.C.A.M., van de' Putte, L.B.A. Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99m Tc pertechnetate uptake measurements. Ann Rheum Dis 1989, 48, 1007–1013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sheldom, P., Webb, C., Roy, S., et al. Treatment of chronic knee effusion with Y-90 correlation of in vitro radiation and chemical effects with clinical results at three and six months. Rheumatol Int 1986, 6, 193–197.

    Article  Google Scholar 

  13. Rubin, L.A., Kurman, C.C., Fritz, M.E., et al. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985, 135, 3172–3177.

    CAS  PubMed  Google Scholar 

  14. Thornthwaite, J.T., Seckinger, D., Sugarbaker, E.V. et al. Dual immunofluorescent analysis of human peripheral blood lymphocyte. Am J Clin Pathol 1984, 82, 48–56.

    Article  CAS  PubMed  Google Scholar 

  15. Boerbooms, A.M.Th., Buijs, W.C.A.M. Rapid assessment of 99m-Tc pertechnetate uptake in the knee joint as a parameter of inflammatory activity. Arthritis Rheum 1978, 21, 348–352.

    Article  CAS  PubMed  Google Scholar 

  16. Mandelbaum, B.R., et al. The use of MRI to assist in diagnosis of pigmented villonodular synovitis of the knee joint. Clin Orthop Rel Res 1988, 231, 135–139.

    Google Scholar 

  17. Poletti, S.C., Gates, H.S., Martinez, S.M., Richardson, W.J. The use of MRI in the diagnosis of pigmented villonodular synovitis. Orthopaedics-PCM 1990, 13(2), 185–190.

    CAS  Google Scholar 

  18. Schumacher, H.R., Lotke, P., Athroya, B., Rothfuss, S. Pigmented villonodular synovitis: light and electron microscopic studies. Semin Arthritis Rheum 1982, 12, 32–43.

    Article  CAS  PubMed  Google Scholar 

  19. Prichard, H.L., Bridgement, J.F., Bleehan, N.M. An investigation of Radioactive Y-90 for the treatment of chronic knee effusion. Br J Radiol 1973, 43, 466–470.

    Article  Google Scholar 

  20. Kyle, V., Hazleman, B.L., Wraight, E.P. Y-90 therapy and Tc-99m pertechnetate knee uptake measurement in the management of rheumatoid arthritis. Ann Rheum Dis 1983, 42, 132–137.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rubin, L.A., et al. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Int Med 1990, 113, 619–627.

    Article  CAS  PubMed  Google Scholar 

  22. Campen, D.H., Horwitz, D.A., Quismorio, D.P., Ehresmaann, G.R., Martin, W.J. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988, 31, 1358–1364.

    Article  CAS  PubMed  Google Scholar 

  23. Keystone, E.C., Snow, K.M., Bombardier, C., Chang, C.H., Nelson, D.L., Rubin, L.A. Elevated soluble IL-2 receptor levels in the sera and synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum 1988, 31, 844–849.

    Article  CAS  PubMed  Google Scholar 

  24. Kinsella, T.D., Vasey, F., Ashworth, M.A. Perturbations of humoral and cellular immunity in a patient with pigmented villonodular synovitis. Am J Med 1975, 58(3), 444–448.

    Article  CAS  PubMed  Google Scholar 

  25. Duke, O., Panayi, G.S., Janossy, G., Poulter, L.W., Tidman, N. Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann Rheum Dis 1983, 42, 357–361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Emery, P., Gentry, K.C., Mackay, I.R., Muirden, K.D., Rowley, M. Deficiency of the suppressor inducer subsets of T lymphocytes in rheumatoid arthritis. Arthritis Rheum 1987, 30, 849–856.

    Article  CAS  PubMed  Google Scholar 

  27. Lasky, H.P., Bauer, K., Pope, R.M. Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. Arthritis Rheum 1988, 31, 52–59.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, DY., Lan, JL. & Chou, SJ. Treatment of pigmented villonodular synovitis with yttrium-90: Changes in immunologic features, Tc-99m uptake measurements, and MR imaging of one case. Clin Rheumatol 11, 280–285 (1992). https://doi.org/10.1007/BF02207973

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207973

Key words

Navigation